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B cell development requires the coordinated action
of transcription factors and cytokines, in particular
interleukin-7 (IL-7). We report that mice lacking the
POZ (Poxvirus and zinc finger) domain of the
transcription factor Miz-1 (Zbtb17DPOZ/DPOZ) almost
entirely lacked follicular B cells, as shown by the
fact that their progenitors failed to activate the
Jak-Stat5 pathway and to upregulate the antiapop-
totic gene Bcl2 upon IL-7 stimulation. We show that
Miz-1 exerted a dual role in the interleukin-7 receptor
(IL-7R) pathway by directly repressing the Janus
kinase (Jak) inhibitor suppressor of cytokine
signaling 1 (Socs1) and by activating Bcl2 expres-
sion. Zbtb17DPOZ/DPOZ (Miz-1-deficient) B cell pro-
genitors had low expression of early B cell genes
as transcription factor 3 (Tcf3) and early B cell factor
1 (Ebf1) and showed a propensity for apoptosis. Only
the combined re-expression of Bcl2 and Ebf1 could
reconstitute the ability of Miz-1-deficient precursors
to develop into CD19+ B cells.
INTRODUCTION
The development of mature functional B cells capable of
producing specific antibodies is a highly regulated, multistep
process that is initiated in the bone marrow, where early B cell
differentiation takes place to yield immature immunoglobulin-M
(IgM)+ B cells. These immature cells can leave the bone marrow
and migrate to the peripheral lymphoid organs, where they
complete their maturation. The earliest step on the way to
become a B cell is the generation of multipotent progenitors
(MPPs) from hematopoietic stem cells (HSCs), which have the
potential to develop into multiple hematopoietic lineages (Chris-
tensen and Weissman, 2001; Morrison and Weissman, 1994).
A subset of MPPs, which expresses the tyrosine kinase receptor
Flt3, loses its ability to differentiate into the erythro-megakar-
yocytic lineage but retains myeloid and lymphoid potential.IWhen these lymphoid-primed multipotent progenitors (LMPPs)
upregulate Flt3 (FMS-like tyrosine kinase 3) expression, they
lose their myeloid potential and become restricted to the
lymphoid lineage (Adolfsson et al., 2005; Ma˚nsson et al., 2007).
The LMPP population contains the early lymphoid progenitors
(ELPs) (Igarashi et al., 2002), which give rise to the common
lymphoid progenitors (CLPs) and, most probably, to the early T
lineage progenitors (ETPs). CLPs can give rise to T cells, natural
killer cells (NK cells), and dendritic cells, but in vivo are consid-
ered the sole progenitors of NK and B cells (Allman et al.,
2003; Kondo et al., 1997b). CLPs retain expression of Flt3 and
express the receptor for IL-7 (IL-7R), which are both critical for
B cell development. Mice deficient for both receptors do not
develop any B cells throughout fetal and adult life (Sitnicka
et al., 2003).
Cytokine signaling and in particular IL-7 is indispensable for
the adult B cell development in the mouse bone marrow (Miller
et al., 2002; Namen et al., 1988). In CLPs, IL-7 signaling induces
the expression of the early B cell factor 1 (Ebf1) (Kikuchi et al.,
2005), which regulates the expression of the transcription factor
Pax5 (paired box gene 5) (O’Riordan and Grosschedl, 1999).
In contrast, Malin and colleagues recently showed that Ebf1
regulation is independent of IL-7 signaling and suggest a role
of IL-7 signaling solely in preventing apoptosis, as it has been
shown for T cells (Malin et al., 2010). Consistent with this, it
has been shown that the expression of Ebf1 is independent of
IL-7 signaling during fetal B cell development (Kikuchi and
Kondo, 2006) and that Il7/ mice still have a few B cells, which
may however originate from a fetal or neonatal precursor
(Carvalho et al., 2001). Also, overexpression of Ebf1 in Il7r/
mice only partially rescues early B cell development (Kikuchi
et al., 2005), suggesting that other factors, induced by IL-7
signaling, must exist to support B cell development such as
E2A (Tcf3), Ebf1, and Pax5 that are required for expression
recombination-activating genes 1 and 2 (Rag1, Rag2) and for
a proper rearrangement of the immunoglobulin heavy chain
locus (IgH) (Lin and Grosschedl, 1995; Nutt et al., 1997; Urba´nek
et al., 1994).
The Miz-1 (Zbtb17) gene encodes a 87 kDa protein with 13
C2H2 zinc finger domains at the carboxy terminal half and
a POZ domain at its N terminus (Peukert et al., 1997). Miz-1
belongs to the group of POZ domain zinc finger transcriptionmmunity 33, 917–928, December 22, 2010 ª2010 Elsevier Inc. 917
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sors. The POZ domain is required for multimerization and for the
interaction with other cofactors that mediate their function
(Staller et al., 2001). Miz-1 binds to core promoters of RNA
polymerase II-dependent target genes and recruits the histone
acetyltransferase EP300 (E1A binding protein 300) and nucleo-
phosmin (Herold et al., 2002; Staller et al., 2001; Wanzel et al.,
2008), which enables transcriptional activation of its targets
such as the genes encoding the negative cell cycle regulators
p15 (Cdkn2b) (Seoane et al., 2001; Staller et al., 2001) or p21
(Cdkn1a) (Phan et al., 2005; Seoane et al., 2002; Wu et al.,
2003). Miz-1 can also form a complex with the bHLH (basic
helix-loop-helix) leucine zipper transcription factor Myc, which
displaces positive cofactors such as EP300 and nucleophosmin
that leads to a repression of Miz-1 target genes (Herold et al.,
2002; Seoane et al., 2001, 2002; Staller et al., 2001; Wanzel
et al., 2008).
In this study we wished to elucidate the role of Miz-1 during
hematopoiesis and have generated a loss-of-function mutant
mouse by gene targeting introducing an allele that allowed the
conditional deletion of the Miz-1 POZ domain. This strategy
specifically disrupted the activity of Miz-1 as a transcriptional
transregulator. Our studies demonstrated that Miz-1 is required
for the very early steps of adult B cell development in the bone
marrow. Importantly, we found that the deletion of the Miz-1
POZ domain severely disrupted signaling events triggered by
IL-7 that substantially affected B cell survival and differentiation
through the regulation of early B cell genes and the antiapoptotic
gene Bcl2.
RESULTS
Generation of Mice Carrying a Conditionally Deficient
Allele of Zbtb17
The complete deletion of the Zbtb17 gene leads to early embry-
onic lethality at E7.5 (Adhikary et al., 2003). To overcome this
limitation, we generated mice carrying loxP (fl) sites flanking
the region encoding the POZ domain to render it amenable to
cre-mediated deletion. Analysis of protein extracts derived
from Zbtb17+/+, Zbtb17+/DPOZ, or Zbtb17DPOZ/DPOZ embryonic
fibroblasts (E12.5) confirmed that this targeting strategy yielded
a truncated Miz-1 protein lacking the POZ domain (Figures S1A
and S1B available online). Previous studies have shown that this
truncated form is nonfunctional as a transcription factor (Staller
et al., 2001; Wanzel et al., 2008) and we could show that this
form is unable to stably bind chromatin (Figure S1C). Adult
Zbtb17fl/fl or Zbtb17+/DPOZ mice were indistinguishable from
wild-type (WT) littermates and were used as control animals
throughout this study, whereas animals with two deleted
Zbtb17 alleles (Zbtb17DPOZ/DPOZ) arrested development at
around E14 (Figure S1D). Because Zbtb17+/DPOZ mice are
phenotypically indistinguishable from Zbtb17fl/fl or wild-type
mice, a dominant-negative effect of the truncated Miz-1 protein
could be excluded.
Miz-1 Is Required for Early B Cell Development
in Adult Mice
Zbtb17 is expressed in lymphoid cells notably in thymus, bone
marrow, and spleen and in purified B and T cell populations (Fig-918 Immunity 33, 917–928, December 22, 2010 ª2010 Elsevier Inc.ure S1E; data not shown). When Zbtb17DPOZ/DPOZ ES cells were
used to generate chimeras, they did contribute to the formation
of organs and hematopoietic cells with the exception of T and B
cells (Figure S1F), strongly suggesting an important role of Miz-1
in lymphoid development. Consistent with this, we observed
a severe defect in B and T cell development when a Vav-cre
transgene was present in the conditional Zbtb17fl/fl mice, which
enabled the deletion of the POZ domain encoding exons in all
hematopoietic cells as previously described (Figure S1G; de
Boer et al., 2003).
In the spleen, Vav-cre Zbtb17fl/fl mice showed a reduction of
the B cell population (B220+) to 10% of control mice (Figure 1A).
Within the residual B220+ cells of Vav-cre Zbtb17fl/fl mice,
frequencies of mature B cells (IgMIgD+) were reduced to half
the values seen in wild-type mice (Figure 1B). In addition, follic-
ular B cells (FO) were reduced in frequency (Figure 1B) and
absolute numbers in Vav-cre Zbtb17fl/fl mice to about 4% of
controls (Figure 1A), whereas marginal zone B cells (MZ)
remained unaffected (Figures 1A and 1B). Similarly, in the bone
marrow of Vav-cre Zbtb17fl/fl mice, cellular frequencies were
strongly reduced and absolute numbers of B220+CD19+ cells
dropped to about 3% of controls (Figures 1C and 1D), indicating
that Miz-1 deficiency leads to a severe reduction of the B cell
compartment, particularly affecting follicular B cells.B Cell Development Is Arrested at the Pre-Pro-B
to Pro-B Cell Transition in Miz-1-Deficient Animals
Hematopoietic progenitors including HSCs, MPPs, and LMPPs
were present in Vav-Zbtb17fl/flmice (Figure 2A). The frequencies
and absolute numbers of CLPs (lin IL-7R+ AA4.1+sca1med
c-kitmed) that are the precursors for the B cell lineage (Izon
et al., 2001; Kondo et al., 1997b) as well as pre-pro-B cells
(linB220+CD43+AA4.1+CD19BP-1HSA) that are contained
within Fraction A (B220+CD43+CD19BP-1HSA) were not
changed in Vav-cre Zbtb17fl/fl mice (Figures 2B–2F). However,
the expression of AA4.1 on CLPs and pre-pro-B cells of Vav-cre
Zbtb17fl/fl mice was severely reduced compared to control mice
(Figures 2B and 2E), whereas IL-7R, c-kit, and Flt3 expression
remained largely unchanged on pre-pro-B cells (Figure 2E).
In addition, Fraction B (B220+CD43+HSA+BP-1CD19+), C,
and C0 cells were almost absent in Vav-cre Zbtb17fl/fl mice
(Figures 2C and 2F) and the proportion of CD19+ cells in Fraction
B was strongly reduced from 92.8% to 31.1% (Figure 2C). This
suggested that Miz-1 is required for the generation of committed
CD19+ B cells; a phenotype that could be confirmed by adoptive
transfer experiments of Miz-1-deficient bone marrow cells into
syngeneic recipients (Figures 3A and 3B; Figures S2A–S2C).
These experiments also showed that hematopoietic stem cells
from Vav-cre Zbtb17fl/fl mice are able to home to the bone
marrow and still have T lymphoid and myeloid potential
(Figures S2A–S2C). However, although T cell development was
severely perturbed, myeloid development was not affected
in the absence of functional Miz-1 (data not shown; Figures
S2A and S2B). Conversely, transfer of control bone marrow
cells into Vav-cre Zbtb17fl/fl mice resulted in a normal lymphoid
and myeloid reconstitution, indicating that the observed
disruption of B cell development is a cell-autonomous pheno-
type (Figures S2D–S2F). Taken together, Miz-1 is required for
Figure 1. POZ Domain Transcription Factor
Miz-1 Is Essential for B Cell Development
(A) Absolute numbers of splenic B cells (B220+),
marginal zone B cells (MZ; B220+CD21+CD23),
and follicular B cells (Foll.; B220+CD21+CD23+)
of control mice (black) and Vav-cre Zbtb17fl/fl
(gray). A minimum of five mice was analyzed for
each group. Error bars indicate standard deviation
(±SD); p values are indicated in the figure.
(B) Flow cytometric analysis of splenic B cells from
control mice and Vav-cre Zbtb17fl/fl mice. B220+
cells were analyzed for surface expression of
IgM and IgD or CD21 and CD23. Immature (I), tran-
sitional (T), mature (M), follicular (FO), andmarginal
zone (MZ) B cells. Numbers in plots indicate
percentages relative to gated B220+ cells.
(C) Absolute numbers of bone marrow B cells
(B220+CD19+; femur and tibia) were corrected to
living cells (based on forward scatter [FSC] and
side scatter [SSC] gating) of control mice (black)
and Vav-cre Zbtb17fl/fl (gray). A minimum of five
mice was analyzed for each group. Error bars indi-
cate standard deviation (±SD); a p value is given in
the figure.
(D) Flow cytometric analysis of bone marrow B
cells from control mice and Vav-cre Zbtb17fl/fl
mice. Cells were analyzed via antibodies for
B220, IgM, and CD19; numbers in dot plots indi-
cate percentages of each gate.
(B and D) Data represent at least three indepen-
dent experiments. Numbers in plots indicate
percentages calculated on live cells (based on
FSC and SSC gating). Controls were either WT,
Vav-cre Zbtb17fl/+, or Zbtb17fl/fl mice.
See also Figure S1.
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Miz-1 Regulates IL-7-Mediated B Cell Developmentthe development of CD19+ B cells and T cells but does not affect
progenitor function and myeloid development.Adult Miz-1-Deficient B Cell Progenitors Fail to Develop
In Vitro in Response to IL-7
LSKs and CLPs from adult Vav-cre Zbtb17fl/fl were purified and
cultured with IL-7 and Flt3L on OP9 cells. Under these condi-
tions, Miz-1-deficient cells did not develop into B220+CD19+ B
cells and were lost from the cultures reproducibly, whereas
progenitors from control animals developed efficiently into B
cells (Figures 3C and 3E). Under myeloid conditions and in the
absence of IL-7, both wild-type and Miz-1-deficient LSK cells
developed into Mac-1+ cells (Figure 3D). To further analyze the
response to IL-7, we cultured CLPs under stroma-free condi-
tions, which have been shown to provide a survival and differen-
tiation signal, but no proliferative stimulus (Miller et al., 2002).
CLPs from control animals differentiated in the presence of
IL-7 into B220+CD19+ B cells, whereas Miz-1-deficient CLPs
did not develop and were again lost from the culture (Figure 3F).
Because DNA content analysis and BrdU (bromodeoxyuridine)-
labeling experiments demonstrated that progression through
the cell division cycle is not disturbed in Miz-1-deficient CLPs
or pre-pro-B cells in vivo (Figure S3), these findings suggested
that loss of Miz-1 function affects those elements of IL-7
signaling that control differentiation and survival but not
proliferation.IA key event in IL-7 signaling is the phosphorylation of Stat5,
which is mediated by Janus kinases (Jaks) upon IL-7 stimulation
(Lin et al., 1995). We found that in Miz-1-deficient
linCD19B220+ or IL-7R+ bone marrow cells, Stat5 phosphor-
ylation was reduced upon IL-7 stimulation compared to similarly
treated control cells (Figures 3G and 3H). To confirm the defect in
IL-7 responsiveness, we stimulated CLPs with IL-7 and found
that several IL-7-responsive genes such as Socs1, Socs3, and
Bcl2 were no longer IL-7- inducible in Miz-1-deficient cells,
whereas a normal upregulation was seen in WT control cells
(Figure 4A). We also observed that the expression of Ebf1,
Mcl1, or Bcl2l1 was not dependent on IL-7 in CLP cells and their
expression level in the presence of IL-7 were not affected byMiz-
1 deficiency (Figure 4A). In freshly isolated CLPs from Vav-cre
Zbtb17fl/fl mice, Socs1 was (35-fold) increased in comparison
to CLPs from control mice (Figure 4B). In contrast, the Miz-1-
overexpressing 70Z/3 pre-B cell line showed a strong reduction
in Socs1 expression (Figure 4B). To identify potential binding
sites of Miz-1 in the Socs1 promoter, we performed chromatin
immunoprecipitation (ChIP) with extracts from 70Z/3 pre-B cells
transduced with a Miz-1-expressing retrovirus, 70Z/3 pre-B
cells, or primary B cells (Figures 4C and 4D; Figures S4A and
S4B). Of note, Miz-1 overexpression in 70Z/3 cells did not influ-
ence their cell cycle progression (Figure S4C). We analyzed
a genomic region of 10 kb and found that Miz-1 bound to
promoter sequences of the Socs1 gene that are close to the
transcription initiator site (Figures 4C and 4D; data not shown).mmunity 33, 917–928, December 22, 2010 ª2010 Elsevier Inc. 919
Figure 2. Miz-1 Function Is Required to Generate Pro-B Cells
Bone marrow cells from control and Vav-cre Zbtb17fl/fl mice were analyzed via flow cytometry.
(A) Lineage-negative and IL-7R-negative cells (lin and IL-7R) were analyzed for c-kit, sca-1, CD34, and Flt3 expression.
(B) Surface expression of lineage marker (lin), IL-7R, sca-1, c-kit, and AA4.1 on bone marrow cells.
(C) Flow cytometric analysis of B220, CD43, HSA, BP-1, and CD19 surface expression on bone marrow cells. B220+CD43+ cells were electronically gated and
analyzed for HSA and BP-1 expression. Fraction B (Fr. B) (B220+CD43+HSA+BP1) cells were analyzed for CD19 expression. Numbers on gates represent
percentages of living cells. Numbers in histograms represent percentages of cells in indicated gates. Fraction (Fr.) A–C0 are indicated on the gates.
(D) Expression of lin, CD19, B220, and CD43 on bone marrow cells. Lineage panel for pre-pro-B cells contains CD11b, Gr-1, Ter119, IgM, TCR-b, TCR-gd, CD8,
CD4, CD3, NK1.1, Ly-6c, and CD5. LinCD19 cells were analyzed for the expression of B220 and CD43.
Numbers in plots indicate percentages calculated on total cells (based on FSC and SSC gating).
(E) The expression of AA4.1, IL-7R, Flt3, and c-kit on pre-pro-B cells (linCD19B220+CD43+). Open histograms represent the expression of each surfacemarker
and filled histograms represent isotype-matched irrelevant antibodies, respectively. Numbers in histograms represent percentages of (linCD19B220+CD43+).
(F) Absolute numbers of CLPs (linIL-7R+AA4.1+sca-1medc-kitmed), pre-pro-B cells (linCD19B220+CD43+AA4.1+), Fr. B cells (B220+CD43+HSABP1CD19+),
Fr. C cells (B220+CD43+HSA+BP1+CD19+), and Fr. C0 cells (B220+CD43+HSAhiBP1+ CD19+). Absolute cells numbers (femur and tibia) were corrected to living
cells (based on FSC and SSC gating) from control mice (black) and Vav-cre Zbtb17fl/fl (gray).
A minimum of five mice was analyzed for each group. Error bars indicate the standard deviation (±SD); a p value is given in the figure. See also Figure S2.
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Figure 3. Miz-1 Is Indispensable for Progen-
itor Differentiation and Survival upon Cyto-
kine Stimulation
(A and B) Lethally irradiated recipients (CD45.1)
were reconstituted with bone marrow cells
(Terr119B220CD19) from WT control mice or
Vav-cre Zbtb17fl/fl mice (both CD45.2+). Bone
marrow cells were analyzed 3–4 months after
transplantation by flow cytometry with antibodies
for CD45.1, CD45.2, B220, and IgM (A) and with
antibodies for CD45.1, CD45.2, B220, and CD19
(B). Data represent three independent experi-
ments. Numbers on gates indicate percentages.
(D, donor; R, recipient.)
(C) LSK (linsca-1+c-kit+) cells from control mice
or Vav-cre Zbtb17fl/fl mice were flow cytometri-
cally sorted and cocultured on OP9 cells in the
presence of Flt3L and IL-7 for 10–12 days. Cells
were analyzed for forward (FSC) and side (SSC)
scatter and the surface expression of B220 and
CD19 by flow cytometry.
(D) LSK (linsca-1+c-kit+) cells from control mice
or Vav-cre Zbtb17fl/fl mice were flow cytometri-
cally sorted and cocultured on OP9 cells in the
presence of a myeloid cytokine cocktail for
6–8 days. Cells were analyzed for FSC and SSC
and the surface expression of Mac1 and CD19
by flow cytometry.
(E) CLP (linIL-7R+sca-1medc-kitmed) cells from
control mice or Vav-cre Zbtb17fl/fl mice were flow
cytometrically sorted and cocultured on OP9 cells
in the presence of Flt3L and IL-7 for 10–12 days.
Cells were analyzed for FSC and SSC as well as
the surface expression of B220 and CD19 by
flow cytometry.
(F) CLP were sorted and cultured under stroma-
free conditions in the presence of Flt3L, IL-7 or
Flt3L, and IL-7 for 6 days. Cells were analyzed
for the surface expression of B220 and CD19 by
flow cytometry.
Data represent at least four (C, E, F) or two (D)
independent experiments.
(G and H) Flow cytometry of Stat5 phosphorylation
in linCD19B220+ (lin: Mac1, Terr119) (G) or in
IL-7R+ bone marrow cells (H) from control mice
or Vav-cre Zbtb17fl/fl mice. Open histograms represent the expression of phospho-Stat5 after 15 min IL-7 stimulation and filled histograms represent
phospho-Stat5 in unstimulated cells, respectively. Data represent three (G) or two (H) independent experiments.
See also Figure S3.
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Miz-1 Regulates IL-7-Mediated B Cell DevelopmentWe could not find a similar binding site in the Socs3 promoter
region (data not shown). This suggested that Miz-1 functions
as a direct transcriptional repressor of the Socs1 gene and that
Socs3 regulation by Miz-1 must be indirect.
Apoptosis in Zbtb17-Deficient B Cells Can Be Partially
Rescued by Bcl2 or Inhibition of Socs1
CLPs or Fraction A cells from Vav-cre Zbtb17fl/fl mice did not
indicate a deregulation of survival genes such as Bcl2 and
Mcl1 or proapoptotic genes like Bad and Bax (Figure 5A), which
is also consistent with findings reported for the IL7r/ mice
(Kikuchi et al., 2005). One exception is Bcl2l1, which we found
slightly downregulated in CLPs from Vav-cre Zbtb17fl/fl mice
(Figure 5A). ChIP on the promoter regions of Bcl2l1 or Ebf1 did
not show Miz-1 binding (data not shown); however, scanning
over a 10 kb region of theBcl2 promoter revealed aMiz-1 bindingIsite about 1.4 kb upstream of the initiator site (Figure 5B; Fig-
ure S5A). Together with the fact that Bcl2 can no longer
be induced by IL-7, these findings suggest that Miz-1 may be
required for the upregulation of Bcl2 upon IL-7 and acts by
directly binding to the Bcl2 promoter at a site different from the
initiator.
To test whether absence of a functional Miz-1 affected the
survival of B lineage cells in vivo, we stained CLPs and pre-pro-
B cells (linB220+CD43+CD19) of Miz-1-deficient mice or
controls with AnnexinV, but we did not find different rates of
cell death (Figure 5C). In contrast, 5- to 10-fold increased
frequencies of apoptotic cells (AnnexinV+) were observed in
linB220+CD43+CD19+ cells (Fraction B–C0) and in B220+
CD43 cells, respectively, in the absence of a functional Miz-1
(Figure 5C), which may explain the loss of committed CD19+
B cells (described in Figure 2).mmunity 33, 917–928, December 22, 2010 ª2010 Elsevier Inc. 921
Figure 4. Miz-1 Is Required to Regulate the
Expression of IL-7-Responsive Genes in CLPs
(A) CLPs from the bone marrow of control and Vav-cre
Zbtb17fl/flmicewereseparatedbyflowcytometriccellsorting
andcultured for 120min in the absenceandpresenceof IL-7.
RNA was extracted and reverse-transcribed and used for
quantitative PCR. Expression of the indicated genes was
measured and normalized to the expression of the Gapdh
gene and is presented as the fold increase relative to
cDNA from control mice or unstimulated cells (set as 1-fold).
Data represent three independent experiments each done in
triplicate. Error bars indicate the standard deviation (±SD).
(B) Expression of Socs1 determined by qRT-PCR in CLPs
from control and and Vav-cre Zbtb17fl/fl mice (left), and in
70Z/3 cells transduced with empty vector (MIGR1) or with
a MIG-Zbtb17-GFP virus (right). Error bars indicate the
standard deviation (±SD).
(C) Socs1 locus, showing coding regions (black boxes)
and noncoding regions (open boxes) and location of
primers (black triangles).
(D) Chromatin immunoprecipitation (ChIP) showing
binding of Miz-1 to the promoter region of Socs1. Used
were a-Miz-1 antibodies (H190) and a-isotype control
antibodies on extracts of MIG-Zbtb17-GFP transduced
70Z/3 cells (left), 70Z/3 cells (middle), or primary B cells
(B220+ cells) (right), followed by a quantitative RT-PCR
via primer pairs of indicated regions. Data represent two
independent experiments each done in triplicate (PCR
on primary B cells was done in duplicates). Error bars indi-
cate the standard deviation (±SD).
See also Figure S4 and Tables S1 and S2.
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Miz-1 Regulates IL-7-Mediated B Cell DevelopmentIn an attempt to counteract this enhanced rate of cell death,
we crossed an H2-K1-Bcl2 transgene, which directs a high
constitutive expression of Bcl2 throughout hematopoiesis,
including HSCs and early lymphoid progenitors (Figure S5B;
Domen et al., 1998; Kondo et al., 1997a) into Vav-cre Zbtb17fl/fl
mice. In the resulting combinatorial mutant animals, B220+
CD19+ B cells were now detected in the bone marrow, reaching
about 40% of control frequencies (Figure 6A). Importantly,
linCD19+B220+CD43+ pro-B cells, which were almost unde-
tectable in Miz-1-deficient mice, now reappeared in the pres-
ence of the H2-K1-Bcl2 transgene (Figure 6A). We also found
that in contrast to CLPs from Vav-cre Zbtb17fl/fl, CLPs from
Vav-cre Zbtb17fl/fl H2-K1-Bcl2mice now survived and expanded
in vitro on OP9 cells (Figure 6B), but gave rise to only a very small922 Immunity 33, 917–928, December 22, 2010 ª2010 Elsevier Inc.number of CD19+ cells, possibly reflecting the
partial rescue seen in vivo (Figure 6A). This indi-
cated that Bcl2 alone is not sufficient to over-
come the developmental block imposed by
Miz-1 deficiency.
Socs1 is a negative regulator of the IL-7
signaling pathway and we did not only observe
high Socs1 expression in Miz-1-deficient CLPs,
but our ChIP experiments also suggested that
Miz-1 directly binds to Socs1 promoter, possibly
modulating its expression. Hence, we reasoned
that inhibitionofSocs1could restore IL-7 respon-
siveness in Miz-1-deficient cells and allow the
development of CD19-positive cells. To test
this, we performed a silencing experiment withgene-specific ‘‘Morpholino’’ oligonucleotides that are able to inter-
ferewith Socs1 protein expression (Figure 6C). LSKs fromVav-cre
Zbtb17fl/fl transfected with Socs1-specific Morpholinos showed
a higher percentage of survival compared to Vav-cre Zbtb17fl/fl
transfected with a control Morpholino. These cells were able to
expandonOP9 cells in the presence of IL-7 but did not upregulate
CD19 (Figure 6D). This suggested that highSocs1 expressionwas
at least partially responsible for the lack of survival of Miz-1-defi-
cient B lineage precursors on OP9 cells in vitro.
Ebf1 and Bcl2 Restore the Ability of Miz-1-Deficient
Precursors to Generate CD19+ B Cells
The inability to fully rescue B cell differentiation inMiz-1-deficient
progenitors by restoration of the IL-7-Stat5-Bcl2 pathway either
Figure 5. Apoptosis during B Cell Development in Miz-1-Deficient Mice
(A) CLPs or Fraction A (CD19B220+CD43+) cells from control and Vav-cre Zbtb17fl/flmicewere separated by flow cytometric cell sorting. RNAwas extracted and
reverse transcribed and used for quantitative PCRwith indicated primer. All valueswere normalized to the expression of theGapdh gene and are presented as the
fraction relative to cDNA from control mice (set as 1-fold). Data show three independent experiments, each done in triplicates. Error bars indicate the standard
error of the mean (±SEM).
(B) Chromatin immunoprecipitation (ChIP) of the binding of Miz-1 to the promoter region of Bcl2. Used were a Miz-1 antibody (H190) and an isotype control anti-
body and extracts ofMIG-Zbtb17-GFP transduced 70Z/3 cells, followed by a qRT-PCR of the indicated genomic regions. Data represent two independent exper-
iments, each done in triplicate. Error bars indicate the standard deviation (±SD). A p value is indicated.
(C) CLPs (linIL-7Ra+c-kitmedsca-1med), pre-pro-B (linB220+CD43+CD19), pro-B (linB220+CD43+CD19+), and Fr. D–F B (B220+CD43) cells were electron-
ically gated and analyzed for apoptotic cells via AnnexinV staining. Numbers in histograms indicate percentages of each indicated gate. Data represent three
independent experiments.
See also Figure S5 and Tables S1 and S2.
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an additional defect exists (Domen et al., 1998; Kondo et al.,
1997a). Comparative expression analysis showed that
lymphoid-specific genes such as Tcf3, Ebf1, Dntt, Pax5, Rag1,
and Rag2 were decreased in Miz-1-deficient CLPs versus
controls (Figure 7A). Ebf1 is essential for B cell development
and responsible for the expression of Pax5 and eventually also
Rag1 and Rag2. Therefore, we expected to be able to rescue
B cell differentiation in Miz-1-deficient cells by overexpressing
Ebf1. We restored Ebf1 expression in Miz-1-deficient progeni-Itors via a murine stem cell virus (MSCV) containing the Ebf1
gene and GFP as a marker (Figure S6A). However, LSK cells
from Vav-cre Zbtb17fl/fl mice transduced with the Ebf1-express-
ing virus did not develop into CD19+ cells and almost all cells
were lost when cultured on OP9-stroma cells, whereas control
LSK cells showed an accelerated differentiation into CD19+
B cells (Figure 7B). Similar to this, forced expression of a rear-
ranged transgenic V(D)J segment at the IgH locus (Cascalho
et al., 1996) did not rescue adult B cell development in Miz-1-
deficient mice (Figure S6B).mmunity 33, 917–928, December 22, 2010 ª2010 Elsevier Inc. 923
Figure 6. Bcl2 Expression or Socs1 Inhibition Enables Miz-1-Deficient Precursors to Survive with IL-7
(A) Flow cytometry analysis of bone marrow from control, Vav-cre Zbtb17fl/fl, and Vav-cre Zbtb17fl/fl H2-K1-Bcl2 mice with the indicated surface markers.
Numbers in dot plots indicate percentages of each gate. Bone marrow cells were analyzed with the pre-pro-B lineage markers (CD11b, Gr-1, Ter119, IgM,
TCR-b, TCR-gd, CD8, CD4, CD3, NK1.1, Ly-6c, and CD5) and B220, CD43 CD19, and IgM to define the pro-B cell population. Numbers in histograms indicate
percentages of pro-B cells for the indicated mice. Data are representative of three independent experiments.
(B) CLP (linIL-7R+sca-1medc-kitmed) cells from control, Vav-cre Zbtb17fl/fl, and Vav-cre Zbtb17fl/fl H2-K1-Bcl2were flow cytometrically sorted and cocultured on
OP9 stroma cells in the presence of Flt3L and IL-7 for 7–8 days. Cells were analyzed for FSC and SSC aswell as the surface expression of B220 and CD19 by flow
cytometry. Data are representative of two independent experiments.
(C) Expression of Socs1 protein in 70Z/3 cells stimulated or not with IL-7 in the presence or absence of an anti-Socs1 Morpholino demonstrates its effect to
knockdown Socs1 protein expression in the presence of IL-7.
(D) Sorted LSKs from control or Vav-cre Zbtb17fl/flmice were incubated with Morpholino against Socs1mRNA or a control Morpholino. Shown is the fluorescein
isothyocyanate fluorescence after incubation, indicative of an almost complete and efficient transfer of morpholino. Cells from control or Vav-cre Zbtb17fl/fl
treated either with control or anti-Socs1 Morpholinos were analyzed after 8 days of OP9 coculture (representative of at least three independent experiments).
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pathway that regulates cell survival and the Ebf1-Pax5-Rag1-
Rag2 axis that regulates differentiation are both affected
by Miz-1 deficiency, a full rescue of B lineage differentiation
might be achieved only if both pathways are restored. To test
this, we sorted LSK cells from Vav-cre Zbtb17fl/fl H2-K1-Bcl2
mice and transduced them with a retroviral vector expressing
Ebf1 or a virus made with an empty vector control. When924 Immunity 33, 917–928, December 22, 2010 ª2010 Elsevier Inc.GFP+ cells obtained after infection were cultured on OP9
cells, those that had received the Ebf1-expressing retrovirus
were indeed able to fully differentiate into CD19+ cells, but
LSKs from Vav-cre Zbtb17fl/fl H2-K1-Bcl2 infected with the
control retrovirus alone did not (Figure 7C). This indicated that
re-expression of both Bcl2 and Ebf1 is needed to restore
B cell differentiation from Miz-1-deficient progenitors and
confirms that the transcription factor Miz-1 is required to
Figure 7. Reconstitution of B Cell Develop-
ment in Miz-1-Deficient Precursors by Ebf1
and Bcl2
(A) CLPs (linIL-7R+c-kitmedsca-1med) were iso-
lated by flow cytometric cell sorting from the
bone marrow of control mice and Vav-cre
Zbtb17fl/fl mice. RNA was extracted and reverse-
transcribed and used for quantitative PCR. All
values are normalized to the expression of the
Gapdh gene and are presented as the fraction
relative to cDNA from control mice (set as
1-fold). Data show three independent experiments
each done in triplicates. Error bars indicate the
standard error of the mean (±SEM).
(B) LSK cells sorted from bone marrow were in-
fected with MIGR1-GFP or MIG-Ebf1-GFP retrovi-
ruses. Transduced cells (GFP+) were FACS
sorted (Figure S6) and equal cell numbers were
directly cultured on OP9 cells in the presence of
SCF, Flt3L, and IL-7. Cells were analyzed for
CD19 and GFP expression by flow cytometry
10–14 days after infection. Numbers on gates indi-
cate percentages. Data are representative of three
independent experiments.
(C) LSK cells were sorted from Vav-cre Zbtb17fl/fl
H2-K1-Bcl2 mice and were infected with MIGR1-
GFP or MIG-Ebf1-GFP retroviruses. After infec-
tion, LSK cells were cultured in the presence of
SCF, Flt3L, and IL-7 on OP9 cells and the GFP+
fraction was isolated by sorting and further
cultured under the same conditions. Cells were
analyzed for CD19 and GFP expression by flow
cytometry 16 days after infection, Numbers on
gates indicate percentages.
Data are representative of two independent exper-
iments. See also Figure S6 and Table S2.
Immunity
Miz-1 Regulates IL-7-Mediated B Cell Developmentregulate survival and developmental networks during early B
cell development.
DISCUSSION
The development of B cells in the adult bone marrow is a well-
defined process, in which cytokine signaling, V(D)J recombina-
tion, and the regulation of gene expression by transcription
factors play a central role (Medina et al., 2004; Singh et al.,
2007). The signal transduction process initiated by IL-7 and its
direct and indirect downstream effectors and also the transcrip-
tion factors Ebf1 and Pax5 are essential for the early commit-
ment and differentiation stages of B cell development. In this
study, we present evidence that the POZ-domain protein Miz-1
(Zbtb17) is essential for B cell development. Our data suggest
that Miz-1 regulates IL-7 signaling by monitoring on one hand
the expression of Socs1, a negative regulator, and on the other
hand Bcl2, a positive effector of IL-7 signaling. In addition,
Miz-1 is required for the proper expression of Tcf3 and Ebf1Immunity 33, 917–928, Dand thus assures the functioning of the
Ebf1-Pax5-Rag1-Rag2 axis.
Cre-mediated Zbtb17 deletion initiated
in hematopoietic stem cells by the Vav
promoter confirmed this and suggested
a role of Miz-1 at a stage of early uncom-mitted B cell progenitors. Flow cytometry data further supported
the view that Miz-1 deficiency affects mainly follicular B cells and
their differentiation, but not the formation of marginal zone B
cells. This is similar to the phenotype reported in Il7- or IL7r-defi-
cient mice (Carvalho et al., 2001; Hesslein et al., 2006), where
most residual peripheral B cells are marginal zone (MZ) B cells.
MZ B cells are long-lived cells and are less affected by the
absence of IL-7 signaling (Hesslein et al., 2006; Lu and Cyster,
2002), which might explain their accumulation in Miz-1-deficient
mice. Hence, the fact that we see a loss of follicular B cells but
not MZ B cells could point to a possible role of Miz-1 in IL-7
signaling. Along this line, the severe drop in absolute CD19+
pro-B cell numbers and the fact that CLP or pre-pro-B cell
numbers were unaffected in Miz-1-deficient mice suggested
a block precisely at the pre-pro-B to pro-B cell transition, which
is very similar to the reported observations in mice deficient for
IL7 or IL7r (Dias et al., 2005; Kikuchi et al., 2005).
Our data clearly show that activation of Stat5 by Jak-mediated
phosphorylation in response to IL-7 is almost undetectable inecember 22, 2010 ª2010 Elsevier Inc. 925
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Zbtb17fl/fl CLPs highly express the Jak inhibitor Socs1 and are
thus unable to upregulate IL-7-responsive target genes. More-
over, our ChIP and mRNA expression data very strongly suggest
that the normal function of Miz-1 during IL-7-dependent early B
cell development is to dampen the expression of Socs1 through
direct binding to its transcription initiator site and to allow the
activation of Stat5 and the subsequent upregulation of IL-7
target genes. Because the inhibition of Socs1 allows Miz-1-defi-
cient cells to survive on OP9 and in the presence of IL-7, it is
conceivable that Miz-1 plays an important role in regulating
IL-7-mediated survival signals.
In a close perspective to our findings, it has been shown that
during early B cell development, Bcl2 expression is highly upre-
gulated in uncommitted ‘‘Fraction A’’ B cells that contain pre-
pro-B cells to provide a survival signal (Li et al., 1993). It has
also been reported that under stroma-free conditions, IL-7 alone
enables CLPs to both survive and differentiate into B220+CD19+
pro-B cells (Kikuchi et al., 2005; Miller et al., 2002). Our expres-
sion analysis showed that in the absence of Miz-1, Bcl2 expres-
sion cannot be upregulated upon IL-7 stimulation in CLPs, and
ChIP experiments demonstrated a direct binding of Miz-1 to
the Bcl2 promoter. This suggests that Miz-1 exerts a second
function in the IL-7R pathway, which is different from the repres-
sion of Socs1 and acts as a direct transcriptional activator of
Bcl2, probably in response to IL-7. Such a role would be consis-
tent with two different reports that have previously demonstrated
that Bcl2 is a direct effector gene of Miz-1 (Patel and McMahon,
2007; Saito et al., 2009).
Miz-1 has been discovered as a Myc binding protein and its
function as a repressor has been described in a complex with
Myc on the promoters of cell cycle regulator genes such as
Cdkn1a and Cdkn2b (Phan et al., 2005; Seoane et al., 2001,
2002; Staller et al., 2001; Wu et al., 2003). None of these Miz-1
targets that regulate cell cycle progression were altered in Miz-
1-deficient cells (data not shown). Consistent with this, we could
not find evidence for disturbed cell cycle progression in Miz-1-
deficient B cell progenitors, suggesting that the regulatory func-
tion of Miz-1 that we describe here is independent of Myc. In
addition, the few remaining peripheral follicular B cells did not
show a proliferation defect (data not shown) in spite of the fact
that they emerged from a disturbed early B cell development.
To obtain further insights in the role of Miz-1 in peripheral follic-
ular B cells, other Cre deleter strains will have to be used.
The knockout of either Ebf1 or Tcf3 leads to a complete block
at the pre-pro-B to pro-B transition (Bain et al., 1994; Lin and
Grosschedl, 1995), which resembles the phenotype seen in
Miz-1-deficient mice. However, Tcf3 is necessary for CLP forma-
tion and E2A-deficient mice have a marked reduction in their
CLP numbers (Bain et al., 1997; Borghesi et al., 2005), which is
different from our observations in the Miz-1-deficient mice. In
addition, E2A is necessary to upregulate Ebf1 for allowing
progenitors to develop into B cells, and ectopic expression of
Ebf1 in Tcf3-deficient progenitors rescued B lymphocyte differ-
entiation (Bain et al., 1994; Seet et al., 2004). In Miz-1-deficient
CLPs, Tcf3 expression is reduced to about 50%and this residual
expression might be sufficient to maintain CLP numbers in Miz-
1-deficient mice but may be the cause of the reduced Ebf1
amounts. It is unlikely that Miz-1 regulates Ebf1 expression926 Immunity 33, 917–928, December 22, 2010 ª2010 Elsevier Inc.directly because ChIP experiments did not provide evidence
for Miz-1 binding on the Ebf1 promoter. It is, however, possible
that Miz-1 acts further upstream and interferes with the expres-
sion of Tcf3 via a mechanism that remains to be elucidated.
If regulation of the E2A-Ebf1-Pax5-Rag1-Rag2 axis would fully
describe the biochemical function of Miz-1, the retrovirally re-
expression of Ebf1 or a rearranged variable heavy chain gene
should have rescued B cell differentiation in Miz-1-deficient
progenitors. However, this is not the case, suggesting that
another defect outside the Ebf1-Pax5-Rag1-Rag2 signaling
pathway must exist in cells lacking Miz-1. A very likely solution
to this is the role ofMiz-1 in the part of IL-7 signaling that provides
a survival signal to B cell progenitors described above. Ectopic
expression of Ebf1 in IL7r/ progenitor cells leads to an initial
development of B220+CD19+IgM+ B cells but cannot overcome
a defect in cell survival (Kikuchi et al., 2005). Our data are consis-
tent with this and corroborate recent reports indicating that regu-
lation of Ebf1 is independent of IL-7 (Malin et al., 2010). Our own
findings that Ebf1 cannot be induced by IL-7 and that re-expres-
sion ofEbf1 alonewas not sufficient to rescueBcell development
in Miz-1-deficient mice confirm this notion further.
When we crossed Miz-1-deficient mice with transgenic mice
overexpressing Bcl2, a substantial but still partial rescue of B
cell differentiation was seen in vivo, but differentiation of Miz-1-
deficient B cell precursors expressing Bcl2 did not occur when
cultured on OP9 stroma in vitro. The introduction of both Bcl2
and Ebf1, which has been shown to promote B cell development
by upregulating B cell genes like Pax5, Rag1 and Rag2, and
Cd19 (Medina et al., 2004; O’Riordan and Grosschedl, 1999;
Pongubala et al., 2008) finally enabled us to fully reconstitute B
cell commitment in Miz-1-deficient precursors when cultured
in vitro. This was evident because only with Bcl2 and Ebf1,
Miz-1-deficient progenitors were able to significantly upregulate
CD19 expression, which indicates that B cell lineage commit-
ment has taken place. We found that Cd19-Cre Zbtb17fl/fl
mice, which excise later than Vav-Cre Zbtb17fl/fl at pro-B and
pre-B stages (Rickert et al., 1997), have normal B cell develop-
ment (data not shown), so we conclude that Miz-1 acts precisely
at the pre-pro-B to pro-B transition, where Ebf1 is critical for
commitment. This experiment supports a comprehensive
model, in which Miz-1 exerts two functions in early B lineage
progenitors: one in the regulation of the IL-7-independent E2A-
Ebf1-Pax5-Rag1-Rag2 axis responsible for B cell differentiation
and another role in the IL-7-dependent upregulation of Bcl2 that
ensures survival of B cell progenitors. In summary, the evidence
that we present here establishes the POZ transcription factor
Miz-1 as a regulatory element required at a critical point where
signals from the IL-7 receptor have to be relayed to effector
genes that mediate survival (such as Bcl2) and to be coordinated
with signals that enable differentiation (such as Ebf1) to allow full
lineage commitment and differentiation along the B cell lineage.EXPERIMENTAL PROCEDURES
Mice
All experiments performed on mice were approved by the IRCM animal care
committee and done in accordance with the regulation of the Canadian
Council of Animal Care.
For additional information see Supplemental Experimental Procedures.
Immunity
Miz-1 Regulates IL-7-Mediated B Cell DevelopmentFlow Cytometry, Cell Surface Staining, Stimulation, and Cell Sorting
Single-cell suspensions were prepared at the time of autopsy from thymus,
bonemarrow, or spleen in PBS supplemented with 1% FCS (staining solution).
Antibody incubation was performed at 4C for 15 min in 1% FCS in PBS (for
more detail see Supplemental Information). For the intracellular flow cytometry
analysis of pStat-5, cells were incubated for 1.5 hr at 37C to shut off endog-
enous signaling prior to stimulation. Cells were harvested, washed with PBS,
and incubated with or without 10 ng/ml IL-7 (Peprotech 217-17) for 15 min
at 37C. After stimulation, cells were fixed with formaldehyde (BD cytofix)
and additionally permeabilized with methanol (BD Phosflow Perm III). Samples
were then stained with anti-phospho-Stat5(Y694)-Alexa488 (BD Phosflow
612598) or Alexa488 Mouse IgG1k isotype control (BD Phosflow). AnnexinV
staining was performed with the AnnexinV-FITC Detection Kit I (Becton Dick-
inson) and by following the manufacturer’s instructions.
Chromatin Immunoprecipitation Assay
ChIP assays were performed with ChIP-IT Express (Active Motif) according to
the manufacturer’s instructions. Cells were fixed with 1% paraformaldehyde
(PFA) neutralized with glycine, washed, and lysed with IGEPAL lysis buffer
(10 mM Tris-HCl, 10 mM NaCl, 3 mM MgCl2, 0.5% IGEPAL, 1 mM PMSF).
The lysate was sonicated (Branson Digital Sonifier). One percent of the soluble
fraction (input) was kept and the rest was precleared with salmon sperm DNA-
Protein G-agarose (Upstate). This was then divided into two tubes and incu-
bated with 15 mg/ml of rabbit anti-Miz-1 polyclonal IgG (H190, Santa Cruz)
or 15 mg/ml rabbit control IgG-ChIP grade antibodies (Abcam). The immune
complexes were then precipitated with Protein G-agarose and eluted accord-
ing to the manufacturer’s instruction. DNA was purified with a polymerase
chain reaction (PCR) purification kit (QIAGEN). Quantitative PCR was per-
formed with the SYBR Green system on the Invitrogen Mx3005. Primers
used for experiments are listed in Table S1.
Retroviral Transduction
Retroviruses were generated with 293-GPG cells. GP+E cells were infected
with retroviruses from the 293-GPG cells for coculture and virus production.
Hematopoietic cells were transduced spin-infection. For spin infection, sorted
LSK cells were resuspended in viral supernatant in the presence of polybrene
(12.5 mg/ml) and were centrifuged by 14003 g for 2 hr. LSK cells were washed
with Opti-MEM and cocultured on OP9 cells (Opti-MEM [10% (vol/vol) FCS,
100 U/ml penicillin, 100 mg/ml streptomycin, 50 mM b-mercaptoethanol] con-
taining 10 ng/ml SCF, 10 ng/ml Flt3L, and 1 ng/ml IL-7). Four to five days after
infection, transduced cells were cell sorted by flow cytometry on the basis of
GFP expression. Coculture transduced cells were plated on OP9 cells. After
4 days of coculture, cells were transferred onto new stroma cells supplied
with new cytokine containing media and cultured for the indicated time
periods.
Morpholino Silencing
LSK cells sorted by flow cytometry were cultured in the presence of SCF, Flt3L,
and IL-7 for 1 hr under stroma-free conditions. Morpholinos were added to the
culture in the presence of EndoPorter followed themanufacturer’s instructions
(Gene Tools, USA). After 4 hr progenitor cells were transferred on OP9 cells.
Every 4 days, cells were transferred on new OP9 cells and new cytokines
were added (see Supplemental Information).
Statistics
Two-tailed Student’s t tests were used to calculate p values where indicated.
A p value% 0.05 was indicated as statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and two tables and can be found with this article online at doi:10.
1016/j.immuni.2010.11.028.
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